Combination of factor vii and a Anti-factor ix and factor x bispecific antibody

RS64646B2Active Publication Date: 2026-06-30LABE FR DU FRACTIONNEMENT & DES BIOTECH SA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
RS · RS
Patent Type
Patents
Current Assignee / Owner
LABE FR DU FRACTIONNEMENT & DES BIOTECH SA
Filing Date
2019-06-14
Publication Date
2026-06-30
Patent Text Reader

Abstract

A pharmaceutical composition comprising: a. transgenic Factor VII and b. a multispecific antibody directed against Factor IX and Factor X. The patent application contains 10 more claims.
Need to check novelty before this filing date? Find Prior Art